Under the terms of the agreement, ViaNautis will receive an initial upfront payment from Lilly, with the short-term potential for additional payments including research-based milestones. Further ...

Donald Trump is headed for a second term in the White House. The pundits have had ample opportunity to dissect the political implications of his victory. For this week’s episode of the IBJ Podcast, we ...

Over in Life Sciences, work continued to progress on the Eli Lilly facility in Indiana. Recent activities include the ...

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased 30.9 acres of vacant land to the north and to the ...

Redwire and Lilly launched a research investigation in November 2023 that successfully demonstrated that insulin crystals grown in microgravity are larger and more ordered than those grown on Earth.

Indianapolis-based pharmaceutical giant Eli Lilly and Company has purchased a 323,930-square-foot industrial building in the ...

Lilly (NYSE: LLY) makes drugs including Mounjaro for type 2 diabetes and Zepbound for obesity. For 2023, it reported $34 ...

Lilly CEO Dave Ricks in Wednesday’s third-quarter earnings call acknowledged that the company is at the mercy of wholesaler ...

Read an update on dividend stocks with strong growth potential and resilience, perfect for navigating election volatility and ...

On the Readout LOUD podcast, hear what a Harris or Trump presidency would mean for health care policy, and learn about Eli ...

The company reported revenue of $11.4 billion and adjusted earnings of $1.18 per share, well below the consensus estimates of $12.1 billion and $1.45, respectively.